Glasgow & Aberdeen Researchers Receive Major Prostate Cancer Funding Boost

Research into prostate cancer received a major boost in January as researchers from the Universities of Glasgow and Aberdeen were given the lead on three of 15 projects from across the UK to be funded by The Prostate Cancer Charity. The Charity is investing over £2 million – its largest contribution to date - in an attempt to target some of the most important research challenges facing prostate cancer, from helping to diagnose the disease through to improving treatment options and quality of life for men living with it. Speaking about the landmark investment Owen Sharp, Chief Executive of The Prostate Cancer Charity, said: “Despite being the most common cancer in men theresearch evidence surrounding prostate cancer is limited. The Charity’s new research portfolio underlines our commitment to finding answers to this often complex and confusing disease. “Over the past three years the Charity has more than trebled its investment in research whilst government funded research into the disease continues to lag behind that of other common cancers. Through our research portfolio we are proud to be working alongside some of the UK’s top scientists to balance out this inequality and tackle some of the critical gaps in knowledge surrounding the disease to ensure men and their families get the answers they need.”

In addition to pumping over £360,000 into two projects at the University of Glasgow and one at the University of Aberdeen. The  Prostate Cancer Charity is funding research at - amongst other institutions - Cambridge University, Imperial College London, Kings College London and the Institute of Cancer Research.

The fifteen grants were awarded via a competitive process of peer review and chosen on the basis of their extremely high quality and relevance to men with prostate cancer. The Prostate Cancer Charity has a strong history of supporting
the delivery of world class research and has invested over £12 million to date.